Risk of Venous Thromboembolism Linked with Comorbidity, Prostate Cancer

Share this content:

the Cancer Therapy Advisor take:

Increased venous thromboembolism (VTE) rates were clinically associated with prostate cancer (PC) and high comorbidity levels in patients, according to an article published online in the journal Cancer.

Participants in the study included 44,035 Danish patients with PC (diagnosed between 1995 and 2011) and 213,810 men from the general population. The participants were matched 5:1 on age, calendar time, and comorbidities.

Results showed 849 of the patients with PC and 2,360 of the men developed VTE within 5 years of follow-up. The patients with PC had a 2.2% risk of developing VTE, while the general population male group had a 1.3% risk.

Patients with PC and high comorbidity levels had a 1-year standardized VTE rate of 15 per 1,000 person-years (PYs) (95% CI: 6.8, 24 per 1,000 PYs)—29% of this rate was attributed to an interaction between PC and comorbidity.

Older patients, patients with metastases, those with a high Gleason score, those in the D’Amico high-risk group, and patients who had surgery were also at a greater risk for developing VTE.

The study suggests that controlling and reducing VTEs associated with comorbidities may influence the overall risk of developing VTE and potentially affect prognosis.

Editor's note: The original version of this article stated that there was a clinical association between pancreatic cancer and VTE, the article has been corrected to reflect the association between VTE and prostate cancer.

Recent research shows that enoxaparin effectively prevents VTE complications in advanced pancreatic
Increased venous thromboembolism rates were clinically associated with prostate cancer and high comorbidity levels.
VTE is a serious complication of cancer. It is unknown whether comorbidity interacts clinically with prostate cancer to increase the VTE rate beyond that explained by prostate cancer and comorbidity alone.
READ FULL ARTICLE From Wiley Online Library

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs